Asprosin is a newly identified adipokine with glucose-raising and appetite-enhancing effects
which acts differently from the known hepatic glucose utilization pathway. This study …

Background Statistical correlation analysis is currently the most typically used approach for
investigating the risk factors of type 2 diabetes mellitus (T2DM). However, this approach …

Poly-herbal therapies for chronic diseases like diabetes mellitus (DM) have been practiced
in south Asia for centuries. One of such therapies comprises of Hordeum vulgare, Elettaria …

Simple Summary Oxidative stress is recognized as one of the pathogenetic mechanisms
underpinning insulin resistance, the hallmark of type 2 diabetes. Although oxidative stress …

Background GLP-1 receptor agonists (GLP-1 RAs) have emerged as an effective therapeutic
class for weight loss. However, the efficacy of these agents in reducing cardiovascular …

Aging continues to be the main cause of the development of Alzheimer's, although it has
been described that certain chronic inflammatory pathologies can negatively influence the …

Depletion of protein phosphatase-1 catalytic subunit beta (PPP1CB), a serine/threonine
protein phosphatase and potent adipogenic activator, suppresses the differentiation of 3T3 …

Obesity is a global health challenge that causes metabolic dysregulation and increases the
risk of various chronic diseases. The gut microbiome is crucial in modulating host energy …

Aims To conduct a randomized controlled trial meta-analysis and provide concise and
specific recommendations for clinical practice optimization of gestational diabetes for …

Tirzepatide is a novel “twincretin” with glucagon-like peptide 1 and glucose-dependent
insulinotropic polypeptide receptor agonist activity, which was recently approved by the …